Dr. Mohammed A. Bari, MD

Dr. Bari practices at Pacific Health Systems in National City, California.

Dr. Bari's NPI, 1679588370, was assigned on July 30, 2006. Dr. Bari graduated from Gandhi Medical College in 1979. Dr. Bari's California license number on file is A46396.

Dr. Bari's primary practice is Pacific Health Systems, at 610 Euclid Ave, National City, CA 91950 in San Diego County. The practice phone is (619) 267-9257.

Dr. Bari's primary practice is Pacific Health Systems in National City, California. The medical group on file is Pacific Health Systems. Dmand AI also links Dr. Bari to 4 more group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bari practices, 4 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Bari's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Bari is board certified in geriatric psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Bari's licenses on file in 4 states: California, Florida, Ohio and Pennsylvania.

Dmand AI lists ADHD, anxiety, bipolar disorder, depression and schizophrenia among the conditions Dr. Bari treats.

CMS data shows 2,138 Medicare services from Dr. Bari across 5 procedure codes in 2024, for 415 Medicare patients. Medicare paid $128,633 for them.

CMS counts 415 Medicare patients who saw Dr. Bari in 2024. The largest group is 65 to 74, with 144 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 76% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bari's median patient age at 62, with 50% women.

In 2024, Dr. Bari wrote 8,329 Medicare Part D claims for 357 patients. 86% of them were for generic drugs. CMS names the drug for 8,132 of them, across 84 drugs with 11 or more claims each, at $3,853,342 in total drug cost. In 2023, CMS named 9,171 claims across 82 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 59 out of 100 for Dr. Bari for performance year 2024, reported as part of a group. Dr. Bari accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Bari. Dr. Bari's most frequent co-authors are Maurizio Fava, MD, Waguih Ishak, MD and Mark Rapaport, MD.

Dmand AI links Dr. Bari to 17 clinical trials, 5 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Schizophrenia, Depressive Disorder and Schizophrenia Spectrum and Other Psychotic Disorders. ACADIA Pharmaceuticals Inc. sponsors the most, 4. Open Payments lists research payments to Dr. Bari that name 7 trials.

CMS Open Payments shows 1,217 general payments to Dr. Bari from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Alkermes, Inc. paid the most, $3,350. It also lists 83 research payments totaling $357,136 from 2016 to 2023, naming 7 clinical trials.

Dmand AI lists 1 award for Dr. Bari, most recently Asst Professor - teacher of the year in 1990.

Dr. Bari graduated from Gandhi Medical College in 1979.

Dr. Bari is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.